Product NDC: | 60505-2512 |
Proprietary Name: | FOSINOPRIL Na |
Non Proprietary Name: | FOSINOPRIL Sodium |
Active Ingredient(s): | 40 mg/1 & nbsp; FOSINOPRIL Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2512 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076906 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050518 |
Package NDC: | 60505-2512-8 |
Package Description: | 1000 TABLET in 1 BOTTLE (60505-2512-8) |
NDC Code | 60505-2512-8 |
Proprietary Name | FOSINOPRIL Na |
Package Description | 1000 TABLET in 1 BOTTLE (60505-2512-8) |
Product NDC | 60505-2512 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FOSINOPRIL Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20050518 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | FOSINOPRIL SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |